Psychological aspects of pre‐symptomatic testing for Machado–Joseph disease and familial amyloid polyneuropathy type I L Rolim, Â Leite, S Ledo, M Paneque, J Sequeiros, M Fleming Clinical genetics 69 (4), 297-305, 2006 | 58 | 2006 |
Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans Games Collaborative Group Journal of Neuroimmunology 179 (1-2), 108-116, 2006 | 36 | 2006 |
Prenatal diagnosis of Machado–Joseph disease by direct mutation analysis J Sequeiros, P Maciel, F Taborda, S Lêdo, JC Rocha, A Lopes, F Reto, ... Prenatal Diagnosis: Published in Affiliation With the International Society …, 1998 | 32 | 1998 |
Twenty years of a pre-symptomatic testing protocol for late-onset neurological diseases in Portugal M Paneque, J Félix, Á Mendes, C Lemos, S Lêdo, J Silva, J Sequeiros Acta Medica Portuguesa, vol. 32 (4), p. 295-304, 2019 | 20 | 2019 |
Mid-and long-term anxiety levels associated with presymptomatic testing of Huntington’s disease, Machado-Joseph disease, and familial amyloid polyneuropathy S Lêdo, Â Leite, T Souto, MA Dinis, J Sequeiros Brazilian Journal of Psychiatry 38, 113-120, 2016 | 15 | 2016 |
Predictive testing for two neurodegenerative disorders (FAP and HD): a psychological point of view L Susana, P Milena, R José, S Jorge Open Journal of Genetics 3 (04), 270, 2013 | 15 | 2013 |
Long-term predictors for psychological outcome of pre-symptomatic testing for late-onset neurological diseases S Lêdo, A Ramires, Â Leite, MAP Dinis, J Sequeiros European journal of medical genetics 61 (10), 575-580, 2018 | 10 | 2018 |
Anxiety and pre-symptomatic testing for neurodegenerative disorders L Susana, J Sequeiros Open Journal of Genetics 3 (02), 14, 2013 | 9 | 2013 |
Ten years of a programme for presymptomatic testing (PST) and prenatal diagnosis (PND) in late-onset neurological diseases in Portugal: Machado-Joseph disease (MJD), Huntington … J Sequeiros, J Pinto-Basto, T Coelho, J Rocha, S Lêdo, Â Leite European journal of Human Genetics 14, 1-1, 2006 | 8 | 2006 |
Depression as the middle-and long-term impact for pre-symptomatic testing of late-onset neurodegenerative disorders S Lêdo, A Leite, T Souto, MAP Dinis, J Sequeiros Temas em Psicologia 24 (2), 579-594, 2016 | 7 | 2016 |
Depression levels in Pre-symptomatic Testing for Neurodegenerative Diseases: a psychological point of view S Lêdo, A Leite, J Sequeiros Journal of Life Medicine 2 (2), 39-50, 2014 | 6 | 2014 |
Impacto psicológico do teste pré-sintomático na doença de Machado-Joseph. Resultados preliminares M Fleming, S Leˆdo, JC Rocha, J Sequeiros Arquivos de Medicina 18 (1/2), 72-75, 2004 | 6 | 2004 |
Long-term Negative Psychological Impact of Presymptomatic Testing for Huntington’s disease ÂMT Leite, MAP Dinis, SMLS Pinto, AMBC Pinto, AIP Gomes, HFP Sousa Journal of Health, Medicine and Nursing 34, 1-9, 2017 | 2 | 2017 |
Pre-symptomatic testing for neurodegenerative disorders: Middle-to long-term psychopathological impact S Lêdo, Â Leite, T Souto, MAP Dinis, J Sequeiros Psicothema 29 (4), 446-452, 2017 | 1 | 2017 |
Familial 18p syndrome--a clinical case C Laranjeira, A Fortuna, A Teixeira, N Teles, S Peres Anales de Pediatria (Barcelona, Spain: 2003) 70 (1), 89-90, 2008 | 1 | 2008 |
Susana Lêdo, Ana Ramires 2, Ângela Leite 2, Maria Alzira P. Dinis 3, Jorge Sequeiros S Lêdo | | 2017 |
La depresión como el indicador de impacto psicológico a la media y largo plazo de la prueba pre-sintomática para enfermedades de aparición tardía S Lêdo, A Leite, T Souto, MAP Dinis, J Sequeiros Temas em Psicologia 24 (2), 579-594, 2016 | | 2016 |
Ataxie avec apraxie oculomotrice de type 2 (AOA2): étude clinique, biologique et corrélation génotype/phénotype d'une cohorte de 90 patients M Anheim, B Monga, M Fleury, P Charles, C Barbot, M Salih, JP Delaunoy, ... Revue Neurologique 166 (1), S14, 2010 | | 2010 |
Author Index Vol. 13, No. 7–8, 2010 KD Christensen, TE Jayaratne, P Javaher, E Nyoungui, L Ioannou, ... Public Health Genomics 13 (7-8), 544-544, 2010 | | 2010 |
Maxia with oculomotor apraxia type 2 (AOA2): Clinical and molecular delineation, genotype to phenotype correlations and strategy for diagnosis M Anheim, M Fleury, P Charles, C Barbot, M Salih, JP Delaunoy, L Arning, ... MOVEMENT DISORDERS 24, S135-S135, 2009 | | 2009 |